IRIS
CARREGA, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 909
NA - Nord America 810
AS - Asia 213
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 1.935
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 810
IE - Irlanda 232
SE - Svezia 213
IT - Italia 185
CN - Cina 166
PL - Polonia 148
UA - Ucraina 26
SG - Singapore 24
DE - Germania 22
FI - Finlandia 21
BE - Belgio 18
GB - Regno Unito 17
VN - Vietnam 14
AT - Austria 9
RU - Federazione Russa 6
CZ - Repubblica Ceca 5
FR - Francia 5
IN - India 5
PH - Filippine 4
A2 - ???statistics.table.value.countryCode.A2??? 1
BR - Brasile 1
EU - Europa 1
LV - Lettonia 1
RO - Romania 1
Totale 1.935
Salva come PNG Salva come JPEG
Città #
Dublin 232
Chandler 188
Nyköping 153
Warsaw 148
Messina 108
Jacksonville 74
Ann Arbor 65
Beijing 58
Ashburn 37
Princeton 37
Medford 34
Des Moines 27
Dearborn 26
Cambridge 25
Boardman 20
Brussels 18
Dong Ket 14
Wilmington 14
Woodbridge 14
Shenyang 13
Jinan 11
San Mateo 11
Nanjing 10
Vienna 9
Zhengzhou 9
Changsha 8
Tianjin 8
Hebei 7
Ningbo 7
Singapore 7
Seattle 6
Taizhou 6
Brno 5
Genova 5
Haikou 5
Aci Bonaccorsi 4
Fuzhou 4
General Mamerto Natividad 4
Guangzhou 4
Nanchang 4
Pune 4
Tappahannock 4
Catania 3
Hangzhou 3
Los Angeles 2
Norwalk 2
Paterno 2
Saponara 2
Washington 2
Andover 1
Auburn Hills 1
Barcellona Pozzo di Gotto 1
Birmingham 1
Blackheath 1
Bremen 1
Brooklyn 1
Bucharest 1
Clarksburg 1
Crawley 1
Elisio Medrado 1
Fiumefreddo Di Sicilia 1
Hefei 1
Houston 1
Jiaxing 1
Kemerovo 1
Lanzhou 1
Las Vegas 1
London 1
Milan 1
Modica 1
Mumbai 1
Munich 1
Palermo 1
Paris 1
Southwark 1
Syracuse 1
Taiyuan 1
Totale 1.491
Salva come PNG Salva come JPEG
Nome #
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 129
Symptomatic carotid atherosclerotic plaques are associated with increased infiltration of natural killer (NK) cells and higher serum levels of NK activating receptor ligands 124
NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. 103
Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells 83
Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells 73
Seroma fluid subsequent to axillary lymph node dissection for breast cancer derives from an accumulation of afferent lymph. 71
The Yin and Yang of Innate Lymphoid Cells in Cancer 71
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 65
CD56(bright) CD16(-) killer Ig-like receptor(-) NK cells display longer telomeres and acquire features of CD56(dim) NK cells upon activation 64
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 64
Cross-dressing: an alternative mechanism for antigen presentation 64
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab 64
The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFN-α Production 63
Human NK cells of mice with reconstituted human immune system components require pre-activation to acquire functional competence. 62
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 58
Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies 58
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 57
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions. 56
Dendritic cell recognition by ILC3 via DNAM-1 triggers pro-inflammatory reciprocal cell activations 53
Natural Killer cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on dendritic cells 48
Principles of NK cell/DC crosstalk: The importance of cell dialogue for a protective immune response 43
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 42
Safety profile of immune checkpoint inhibitors: An analysis of the Italian spontaneous reporting system database 41
Human NK cells and NK receptors. 40
Characterization of human afferent lymph dendritic cells from seroma fluids. 40
Predictive Immunologic Markers of Response to Nivolumab in Non-Small Cell Lung Cancer 40
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules 39
Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS) 38
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer 37
Isolation, Expansion, and Characterization of Natural Killer Cells and Their Precursors as a Tool to Study Cancer Immunosurveillance 33
Identification of Natural Killer Cells in Tissues and Their Isolation 32
Natural killer cells infiltrating human non small-cell lung cancer are enriched inCD56 bright CD16(-) cells and display an impaired capability to kill tumor cells. 32
Characterisation of innate lymphoid cell subsets infiltrating colorectal carcinoma 32
ILC in chronic inflammation, cancer and targeting with biologicals 32
The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-alpha production. 23
Mechanical bacterial lysate enhances antimicrobial barrier mechanisms in human airway epithelial cells 21
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 19
Natural killer cell distribution and trafficking in human tissues. 18
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade 11
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy 4
Murine models to study human NK cells in human solid tumors 2
Totale 2.049
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.123
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020254 17 6 4 10 2 27 20 54 6 44 40 24
2020/2021463 20 14 54 62 52 28 34 22 32 65 50 30
2021/2022264 9 31 3 16 13 8 29 17 5 16 34 83
2022/2023728 67 68 39 61 49 72 8 52 273 2 15 22
2023/2024173 13 28 29 12 14 23 1 9 6 4 4 30
2024/202511 11 0 0 0 0 0 0 0 0 0 0 0
Totale 2.049